Lisa Lynn Decker, Chief Business Officer at IGM Biosciences, Inc. (IGMS), sold 2,484 shares at $18.77 ($47K) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Open-market sale of $47k IGMS by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.77 | 1,598 | $30K | 63.6% |
| 2 | $19.36 | 886 | $17K | 36.4% |
| Total | $18.98 avg | 2,484 | $47K | 100% |
| Filing → |
| IGMS | SELL | 2025-03-18 | $6K | — | Filing → |
| IGMS | SELL | 2024-12-18 | $8K | — | Filing → |
| IGMS | SELL | 2024-09-17 | $11K | — | Filing → |